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Abstract 
BACKGROUND: As the most cause of death in patients with solid extracranial malignancy, brain metastasis (BM) 
nowadays being studied extensively especially on how to find a reliable laboratory marker that can correlate with 
its clinical outcome. Leukocyte subtypes, primarily neutrophils and lymphocytes and its ratio known as 
Neutrophils-Lymphocyte Ratio (NLR) have been known before its relationship with progressivity of BM from other 
solid tumours.  
AIM: The objectives of this research to study the correlation of leukocyte subtypes, neutrophil-lymphocyte ratio & 
functional outcome in brain metastasis. 
METHODS: The study subjects were recruited consecutively from the study population. Venous blood was taken 
5 ml of venous blood samples done in the first day of admission on emergency department and neurology clinic of 
Neurology Department of Adam Malik General Hospital before any drug injections. Samples were kept in 
vacutainer tubes containing ethylenediaminetetraacetic acid (EDTA) and sent to Department of Clinical Pathology 
laboratory of Adam Malik General Hospital, immediately centrifuged at 3100 rpm for 10 minutes in -20°C 
temperature and analysed using Sysmex XT-2000i. Functional outcome of the patient assessed using Karnofsky 
performance scale (KPS) in a cross-sectional manner with laboratory analysis. 
RESULTS: We conduct a mean differences and correlational leukocytes and its subsets analysis of 72 BM 
patients resulting on significant positive correlation on lymphocyte percentage (r = 0.383, p = 0.001) and 
lymphocyte absolute (r = 0.265, p = 0.024), also significant negative correlation on neutrophils (r = -0.240, p = 
0.042) and NLR (r = -0.432, p < 0.001) with Karnofsky Performance Scale (KPS). 
CONCLUSION: Increased lymphocyte absolute and lymphocyte percentage correlated significantly (p < 0.05) 
with better KPS, while elevated neutrophils percentage and increased NLR show significant correlation with worse 
outcome of BM patients. 
 
 
 
 
 
Introduction 
 
Brain metastasis (BM) is one of the central 
nervous system consequences of primary extracranial 
malignancy that mainly happen on 20-40% in adult 
cancer patients. As one of the main cause of death for 
these population, its progression is determined by 
several condition such tumour cell migration 
(intravasation, dissemination and extravasation) and 
colonisation also microenvironment inflammation that 
correlates in the severity of the disease. The basic 
mechanism of BM begin with Paget’s “seed and soil” 
hypothesis included three main principles: the 
heterogeneous population of a tumour with different 
characteristics, specific traits of metastasis and 
secondary tumoral microenvironment [1], [2], [3], [4]. 
The human immune system, in general, have 
several myeloid cells especially leukocyte subtypes 
which are responsible in cancer metastasis regulation, 
such neutrophils and monocytes; both considered 
immunocytes that could secrete vascular endothelial 
growth factor (VEGF) contributing to increased tumour 
size and development. While regulation of aspartic 
proteinase cathepsin E, which act as tumour 
suppressor activated by lymphocytes, macrophage 
and a dendritic cell which and apoptosis induction [5], 
[6].  
Neutrophil-to-lymphocyte ratio (NLR) is the 
ratio of the absolute neutrophil count to the absolute 
lymphocyte count and used as one of a simple, rapid, 
cost-effective and indicative marker of inflammatory 
process and stress of human body as it can be 
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obtained on complete blood count (CBC) analysis. 
While normal immune system would prevent the 
dissemination of cancer cells and prevent 
proliferation, about 0.01% escaping circulating tumor 
cells (CTC) survival from primary sites resulting from 
shear stress, mechanical detachment even cell-
mediated cytotoxicity which provoked epithelial to 
mesenchymal transition (EMT) regulated by tumor 
necrosis factor α (TNF- α) and nuclear factor κβ (NF- 
κβ). Individual immunocompetence capability could 
also be estimated by NLR and correlated with disease 
progression and functional outcome in malignancy 
measured by Karnofsky performance scale (KPS) [5]. 
On this basis, elevated NLR ratio could be 
consequences of either neutrophilia which promotes 
tumour granulocyte colony-stimulating factor (GM-
CSF) and/or lymphopenia that can cause circulating 
tumour cell escape systemic immunosurveillance in 
the human body [5], [6]. 
Growing interest of NLR count on has been 
established today as several studies tried to elaborate 
between this ratio and progression of the disease that 
implicated by even slight process of inflammation, for 
examples malignancy in various primary organ (e.g.: 
small cell lung cancer, renal cell carcinoma, 
pancreatic cancer, primary liver ca, breast cancer, 
glioblastoma multiforme), arterial disease (e.g: acute 
coronary syndrome, cerebral infarction, Takayasu 
arteritis), degenerative disease (e.g: ankylosing 
spondylitis) also in some autoimmune disorders (e.g: 
psoriasis, systemic lupus erythematosus [SLE]) [7], 
[8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], 
[19]. 
 
 
Methods 
 
Ethical approval received from the Health 
Research Ethical Committee, Faculty of Medicine 
Universitas Sumatera Utara, Medan-Indonesia. The 
research was conducted from January 2016 to 
December 2016 at Adam Malik General Hospital 
recruiting 72 consecutive sample of patients 
diagnosed with BM. Confirmation of BM diagnosis 
was done by means if there are any clinical neurologic 
deficits and/or any suspicious prove of in any 
established modalities (laboratory tumour markers, 
chest radiography, ultrasonography, computed 
tomography (CT) scan, radionucleotide tracing and/or 
another diagnostic test) supporting central nervous 
system (CNS) involvement from other extracranial 
primary malignancy [20]. 
Exclusion criteria in this study including 
sepsis, septicaemia, bacteremia, septic shock and 
other systemic inflammatory response syndrome 
(SIRS)-like condition, leukemia and leukemoid 
reaction, prior dexamethasone, methylprednisolone 
and/or any intravenous steroid injection, autoimmune 
disease (e.g: SLE, scleroderma) or immunodeficient 
syndrome (e.g: HIV/AIDS) essentials heart,liver and/or 
kidney disorders, pneumonia, seizure at the beginning 
or during hospitalization, massive upper and/or lower 
GI bleeding which all of the above could modify, 
primarily suppress the baseline immunological 
condition of the patients [21], [22], [23]. 
Informed consent was asked from the patients 
(or their legal responders in any means the patients 
cannot give consent) and collection of 5 ml of venous 
blood samples done in the first day of admission on 
emergency department and/or neurology clinic of 
Neurology Department of Adam Malik General 
Hospital before any drug injections. Samples were 
kept in vacutainer tubes containing 
ethylenediaminetetraacetic acid (EDTA) and sent to 
Department of Clinical Pathology laboratory of Adam 
Malik General Hospital, immediately centrifuged at 
3100 rpm for 10 minutes in -20o C temperature and 
analysed using Sysmex XT-2000i. Functional 
outcome of the patient assessed using Karnofsky 
performance scale (KPS) in a cross-sectional manner 
with laboratory analysis.  
Data were collected and calculated using IBM 
SPSS Statistic for Windows, Version 24.0 and test of 
normality was conducted using Kolmogorov-Smirnov 
on more than 50 study sample. Variables 
characteristics were shown in Table 1 while mean 
differences were compared between groups using 
one-way analysis of variant (ANOVA) (Table 2), and 
each variable was correlated with KPS using 
Pearson’s correlation test on the nature of normal 
distribution of the samples (Table 3). 
 
 
Result 
 
We divided subjects into 3 categorised KPS 
groups (KPS 80-100 as symptomatic, KPS 50-70 as 
symptomatic with assistance and KPS 0-40 as 
symptomatic with bed confinement). Test of normality 
was conducted using Kolmogorov-Smirnov test on 
more than 50 study sample. Variables characteristics 
of the patients were shown in Table 1.  
Table 1: Characteristics of BM Subjects 
Variable Characteristics (n = 72) Mean (Percentage) 
Age 
 Minimum 
 Maximum 
Sex 
 Male 
 Female 
Origins of Primary Tumor 
 Pulmonary 
 Breast 
 Cervix-genito-urinary 
 Others 
 Unknown 
KPS 
 80-100 
 50-70 
 0-40 
51.74 ± 11.17 years old 
22 years old 
74 years old 
 
30 (41.7%) 
42 (58.3%) 
 
37 (51.4%) 
17 (23.6%) 
10 (13.9%) 
4 (5.55%) 
4(5.55%) 
 
10 (13.89%) 
34 (47.22%) 
28 (38.89%) 
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Mean differences were also compared 
between groups using analysis of variant (ANOVA) 
(Table 2). 
Table 2: Means Difference of Leukocyte Subtypes 
Variables  Karnofsky Performance Scale (KPS) Groups P 
 Total Subjects 
KPS 
80-100 
(n = 10) 
KPS 
50-70 
(n = 34) 
KPS 
0-40 
(n = 28) 
 
Mean Leukocytes 
(x103/mm3) 
11.93 + 5.96 11.48 + 5.69 11.14 + 5.38 13.05 + 6.70 0.446 
Mean Neutrophil 
Percentage (%) 
78.28 + 9.74 73.21 + 10.34 77.75 + 8.86 80.74 + 10.09 0.099 
Mean Neutrophil 
Absolute ( x 103/µL) 
9.57 + 5.29 8.71 + 5.01 8.83 + 4.62 10.79 + 6.06 0.303 
Mean Lymphocyte 
Percentage (%) 
13.18 + 7.68 17.03 + 9.39 14.81+ 7.89 9.84 + 5.38 0.008* 
Mean Lymphocyte 
Absolute ( x 103/µL) 
1.40 + 0.74 1.66 + 0.74 1.47 + 0.67 1.23 + 0.81 0.217 
Mean Monocyte 
Percentage (%) 
7.14 + 3.21 7.04 + 2.38 7.45 + 3.42 6.81 + 3.28 0.739 
Mean Monocyte 
Absolute ( x 103/µL) 
0.90 + 0.63 0.92 + 0.66 0.94 + 0.67 0.84 + 0.60 0.827 
Mean Basophil 
Percentage (%) 
0.31 + 0.36 0.40 + 0.36 0.36 + 0.42 0.21 + 0.28 0.202 
Mean Basophil 
Absolute ( x 103/µL) 
0.03 + 0.03 0.04 + 0.05 0.03 + 0.03 0.03 + 0.03 0.424 
Mean Neutrophil-to- 
Lymphocyte Ratio 
(NLR) 
8.23 + 5.05 5.62 + 2.94 6.87 + 4.02 10.82 + 5.72 0.001* 
*significant p-value (< 0.05).  
 
Each variable was then correlated with KPS 
using Pearson’s correlation test on the nature of 
normal distribution of the samples as seen in Table 3. 
Table 3: Pearson’s Correlation of Leukocytes Subtypes and 
KPS 
 Karnofsky Performance Scale 
Leukocytes Subtype r (Pearson’s Correlation) p (Significance) 
Leukocytes (x10
3
/mm
3
) -0.569 0.625 
Neutrophil Percentage (%) -0.240 0.042* 
Neutrophil Absolute 
( x 10
3
/µL) 
-0.106 0.375 
Lymphocyte Percentage (%) 0.383 0.001* 
Lymphocyte Absolute 
( x 10
3
/µL) 
0.265 0.024* 
Monocyte Percentage (%) 0.100 0.405 
Monocyte Absolute 
( x 10
3
/µL) 
0.121 0.311 
Basophil Percentage (%) 0.188 0.115 
Basophil Absolute 
( x 10
3
/µL) 
0.153 0.200 
Neutrophil-to- Lymphocyte Ratio 
(NLR) 
-0.432 < 0.001* 
*significant p-value (< 0.05). 
 
 
 
Discussion  
 
On the mean differences and correlational 
analysis, we found significant differences on mean 
lymphocyte percentage between symptomatic group 
(KPS 80-100), symptomatic with assistance group 
(KPS 50-70) and symptomatic with bed confinement 
group (KPS 0-40), (17.03 ± 9.39% vs 14.81 ± 7.89% 
vs 9.84 ± 5.38 %, respectively) with Pearson 
correlation product moment of lymphocyte percentage 
and KPS show rather weak but significant positive 
correlation (r = 0.383; p = 0.001) [24].  
Although we were not getting any ANOVA’s 
significant differences on mean neutrophile 
percentage and meant lymphocyte absolute, there are 
weak significant negative correlation on neutrophile 
percentage and KPS (r = -0.240, p = 0.042) also on 
lymphocyte absolute and KPS show weak significant 
positive correlation on lymphocyte absolute and KPS 
(r = 0.265, p = 0.024). This view was in line with my 
review on multiple tumour progression correlated with 
tumour-infiltrating neutrophils, as elevated blood 
neutrophils proven to be a poor prognostic factor for 
functional outcome [25] also stated that circulating 
tumour-infiltrating-lymphocyte number elevation also 
has correlated with favourable clinical outcomes in 
subsets of human cancer [26]. 
On NLR variable, we found significant mean 
differences percentage between symptomatic group 
(KPS 80-100), symptomatic with assistance group 
(KPS 50-70) and symptomatic with bed confinement 
group (KPS 0-40) (5.62 ± 2.94 vs 6.87 ± 4.02 vs 10.82 
± 5.72, respectively) and also significant moderate 
negative correlation between NLR and KPS (r =          
-0.432, p < 0.001). Although applied on different 
population (Glioblastoma Multiforme/ GBM), NLR also 
has been studied by Alexiou et al., resulting on NLR > 
4.7 was associated with decreased survival time (11 
vs 18.7 months, p = 0.01) [7]. 
Templeton et al., allege that high NLR has an 
adverse effect on overall survival (OS) in many solid 
tumours [27], and this result was also agreeable with 
the previous study by Serdarevic et al., [28] on BM 
and non-BM population of non-small-cell lung cancer 
(NSCLC) which conclude higher NLR mean on BM 
group and more progressive condition (6.05 vs 4.6, p 
= 0.023) [28]. This was also confirmed by another 
prognostic study of NLR that elevated preoperative 
NLR is a predictor of worse survival after BM 
resection (OS 14 month for NLR < 5 and 5 months for 
NLR ≥ 5, p = 0.001) [27], [29]. 
In conclusion, increased lymphocyte absolute 
and lymphocyte percentage correlated significantly 
with better KPS, while elevated neutrophils 
percentage and increased NLR show significant 
correlation with worse outcome of BM patients.  
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